The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy.
暂无分享,去创建一个
[1] P. Schraeder,et al. Stress and sudden death , 2006, Epilepsy & Behavior.
[2] S. Priori,et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.
[3] M. Ackerman,et al. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. , 2011, Heart rhythm.
[4] P. Schwartz. Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. , 2010, Heart rhythm.
[5] E. W. Hancock,et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the , 2009, Journal of the American College of Cardiology.
[6] Li Zhang,et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. , 2005, Heart rhythm.
[7] P. Schwartz,et al. Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. , 2012, Journal of the American College of Cardiology.
[8] P. Schwartz,et al. Nadolol Block of Nav1.5 Does Not Explain Its Efficacy in the Long QT Syndrome , 2012, Journal of cardiovascular pharmacology.
[9] P. Schwartz. Newborn ECG screening to prevent sudden cardiac death , 2006 .
[10] R. Hauer,et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.
[11] P. Schwartz,et al. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. , 1976, The American journal of cardiology.
[12] M. Ackerman,et al. Competitive sports participation in athletes with congenital long QT syndrome. , 2012, JAMA.
[13] L. Jordaens,et al. Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry , 2010, Circulation.
[14] S. Priori,et al. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. , 2006, European heart journal.
[15] A. Moss,et al. Stress and sudden death. The case of the long QT syndrome. , 1991, Circulation.
[16] M. Ackerman,et al. Epinephrine QT Stress Testing in the Evaluation of Congenital Long-QT Syndrome: Diagnostic Accuracy of the Paradoxical QT Response , 2005, Circulation.
[17] S. Priori,et al. Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers , 2004 .
[18] A Malliani,et al. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. , 1975, American heart journal.
[19] A. Wilde,et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. , 2010, Journal of the American College of Cardiology.
[20] S. Priori,et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. , 2004, JAMA.
[21] Lia Crotti,et al. Long-QT syndrome: from genetics to management. , 2012, Circulation. Arrhythmia and electrophysiology.
[22] J. Graham,et al. Genetic Testing for Long-QT Syndrome: Distinguishing Pathogenic Mutations From Benign Variants , 2010 .
[23] Carlo Napolitano,et al. Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.
[24] G. Breithardt,et al. Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .
[25] P. Schwartz. Cutting nerves and saving lives. , 2009, Heart rhythm.
[26] S. Priori,et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2000, Circulation.
[27] A. George,et al. Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.
[28] P. Schwartz,et al. All LQT3 patients need an ICD: true or false? , 2009, Heart rhythm.
[29] S. Priori,et al. The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge , 2000, Circulation.
[30] M. Ackerman,et al. β-Blocker Therapy Failures in Symptomatic Probands with Genotyped Long-QT Syndrome , 2004, Pediatric Cardiology.
[31] P. Schwartz,et al. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? , 2006, Journal of the American College of Cardiology.
[32] P. Schwartz,et al. Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel , 2008, Circulation. Arrhythmia and electrophysiology.
[33] R. Gow. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2001, Circulation.
[34] Bba,et al. Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene , 2007, Circulation.
[35] S. Priori,et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. , 2004, Heart rhythm.
[36] Calum A MacRae,et al. Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.
[37] M. Arita,et al. Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes. , 1996, Journal of molecular and cellular cardiology.
[38] D. Tester,et al. Diagnostic Miscues in Congenital Long-QT Syndrome , 2007, Circulation.
[39] B. Kerem,et al. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? , 2000, Circulation.
[40] P. Schwartz,et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. , 1994, Journal of the American College of Cardiology.
[41] M. Ackerman,et al. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. , 2010, Heart rhythm.
[42] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[43] R. Myerburg,et al. Electrocardiograms Should Be Included in Preparticipation Screening of Athletes , 2007, Circulation.
[44] P. Schwartz,et al. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. , 2010, Heart rhythm.
[45] S. Priori,et al. High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” , 2009, Circulation.
[46] Peter J. Schwartz,et al. Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.
[47] D. Tester,et al. Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice , 2011, Circulation.
[48] H. L. Stone,et al. Effects of Unilateral Stellectomy upon Cardiac Performance during Exercise in Dogs , 1979, Circulation research.
[49] D. Tester,et al. Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes , 2004, Circulation.
[50] P. Schwartz,et al. Idiopathic long QT syndrome: progress and questions. , 1985, American heart journal.
[51] Michael J Ackerman,et al. Genetic Testing for Long-QT Syndrome: Distinguishing Pathogenic Mutations From Benign Variants , 2009, Circulation.
[52] Fabio Mosca,et al. Prevalence of the Congenital Long-QT Syndrome , 2009, Circulation.
[53] S. Popov,et al. [Long Q-T syndrome]. , 1986, Kardiologiia.
[54] P. Schwartz,et al. QTc behavior during exercise and genetic testing for the long-QT syndrome. , 2011, Circulation.
[55] M. Ackerman,et al. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. , 2009, Heart rhythm.
[56] Derick R. Peterson,et al. Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel , 2002, Circulation.
[57] S. Priori,et al. Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.
[58] A. Wilde,et al. Exercise extreme caution when calling rare genetic variants novel arrhythmia syndrome susceptibility mutations. , 2010, Heart rhythm.
[59] A. Moss,et al. The Common Long-QT Syndrome Mutation KCNQ1/A341V Causes Unusually Severe Clinical Manifestations in Patients With Different Ethnic Backgrounds: Toward a Mutation-Specific Risk Stratification , 2007, Circulation.
[60] S. Priori,et al. Long QT Syndrome: Genotype-Phenotype Correlations , 2004 .
[61] Michael J. Ackerman,et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. , 2011, Journal of the American College of Cardiology.
[62] Y. Gedik,et al. The Jervell and Lange-Nielsen syndrome. , 1994, International journal of cardiology.
[63] A. Moss,et al. The long QT syndrome: a prospective international study. , 1985, Circulation.
[64] H. L. Stone,et al. Left stellectomy and denervation supersensitivity in conscious dogs. , 1982, The American journal of cardiology.
[65] Peter J. Schwartz,et al. Clinical aspects of ventricular repolarization , 1989 .
[66] D. Tester,et al. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. , 2004, Heart rhythm.
[67] Lauri Toivonen,et al. The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome , 2006, Archives des maladies du coeur et des vaisseaux.
[68] E. W. Hancock,et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American , 2009, Journal of the American College of Cardiology.
[69] Barry J Maron,et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. , 2009, European heart journal.
[70] M. Bitner-Glindzicz,et al. The Jervell and Lange-Nielsen syndrome. , 2000, Advances in oto-rhino-laryngology.
[71] S. Priori,et al. Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients , 2007, Circulation.
[72] A. Moss,et al. Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type‐3 Long‐QT Syndrome , 2008, Journal of cardiovascular electrophysiology.